Editor’s note: This is a developing news story. Please check back soon for updates.
Bausch + Lomb will return its enVista IOLs to market after identifying the event that led to a voluntary recall, according to a press release.
The company recalled the lenses in March after receiving reports of toxic anterior segment syndrome (TASS) among patients implanted with the IOLs in the U.S.
Bausch + Lomb conducted an investigation with the help of nearly 30 cataract surgeons, including leaders from the American Society of Cataract and Refractive Surgery, and (Read more...)